Home › Trial NCT07785843
A Clinical Study of V503 in Chinese Females Who Have Previously Received a Bivalent Human Papillomavirus (HPV) Vaccine (V503-108)
- Trial IDNCT07785843
- StatusRecruiting
- PhasePhase 3
- Study typeInterventional
- SponsorMerck Sharp & Dohme LLC
- Enrollment930
- Start date2026-10-10
- ConditionsPapillomavirus Infections
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.